MOHAMMAD MOBAYED (MD) – Hematology & Oncology Physician, NPI 1114134632
Hematology & Oncology Physician
Main info
Doctor Profile
Profile Insights
NPPES metrics only — not quality of care.
476 HEMATOLOGY/ONCOLOGY in MI
Provider Addresses for MOHAMMAD MOBAYED (MD)
25625 SCHOENHERR RD STE 300
WARREN, MI 480891499
Phone: (586) 298-2357
Type: Location
PO BOX 7175
BLOOMFIELD, MI 483027175
Phone: (313) 655-1616
Fax: (586) 690-7235
Type: Mailing
3950 S ROCHESTER RD STE 1400
ROCHESTER HILLS, MI 483075160
Phone: (248) 494-4444
Fax: (586) 690-7235
Type: Location
Farmington Hills Post Office, 32455, West 12 Mile Road, Farmington Hills, Oakland County, Michigan, 48377, United States
FARMINGTON HILLS, MI 483333278
Phone: (586) 298-2357
Fax: (586) 281-9616
Type: Mailing
43928 MOUND RD STE 100
STERLING HEIGHTS, MI 483142081
Phone: (586) 298-2357
Type: Location
NPPES updates history
No NPPES updates recorded for this provider.
Prescription Activity
Loading prescription activity...
Open Payments (CMS)
CMS reports 244 Open Payments records for all available years, with a total value of $8,180.
Total Amount is formed as General ($8,180) + Research ($0) + Ownership ($0) = $8,180.
Last reported payment date: 2024-12-26 • Largest payer in this snapshot: US Oncology Corporate, Inc. ($2,391).
Total Amount
$8,180
General + Research + Ownership
Payments
244
Total payment records
General Amount
$8,180
General payments
Research Amount
$0
Research funding
Ownership Amount
$0
Ownership interests
Ownership Count
0
Ownership records
Last Payment Date
2024-12-26
Latest reported date
Top Companies
Largest payers in this snapshot
| Company | Amount |
|---|---|
| US Oncology Corporate, Inc. | $2,391 |
| AstraZeneca Pharmaceuticals LP | $803 |
| Genentech USA, Inc. | $314 |
| SOBI, INC | $243 |
| Incyte Corporation | $190 |
Medicare Enrollment & Revalidation
Source: CMS public data · Not endorsed by CMS ·
Educational use only—not medical, billing, or legal advice.
PECOS enrollment status
Participating (accepts Medicare assignment)
Enrollment effective: 2018-08-29
PECOS data refreshed: 2026-05-27
Medicare revalidation (CMS due date list)
Due date not assigned yet
CMS is tracking this Medicare enrollment for revalidation, but has not published a due date.
Enrollment records
1
Earliest due date
Not assigned (TBD)
CMS data updated
2026-06-01
Revalidation progress
- Medicare enrolled
- On CMS revalidation list
- Due date assigned
- Revalidate in PECOS
CMS enrollment records
| Enrollment ID | Type | Specialty | State | Due date |
|---|---|---|---|---|
| I20180829002091 | I | Hematology/Oncology | MI | TBD |
What to do next
- No action required while the due date shows TBD.
- Check the CMS Revalidation Lookup Tool periodically — CMS updates the list about every 60 days.
- Do not submit a revalidation application in PECOS until CMS publishes a concrete due date.
Prepare CMS-855 application → · Look up this NPI in PECOS → · Verify on CMS PECOS
Medicare Utilization (FFS)
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·
Educational use only—not medical, billing, or legal advice.
Top Medicare procedures (2023) · refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Medicare allowed |
|---|---|---|---|---|
| J1437 | Injection, ferric derisomaltose, 10 mg | 1,600 | 12 | $0 |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 418 | 120 | $0 |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 364 | 123 | $0 |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 160 | 130 | $0 |
| 96372 | Injection of drug or substance under skin or into muscle | 128 | 21 | $0 |
Insurance plans in this area (ZIP 48089)
Loading plans...
Reviews
All reviews are moderated before publication. Reviews reflect users' opinions; we do not verify the accuracy of individual reviews.
No reviews yet. Be the first to share your experience — your opinion helps families compare providers.